UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000003282
Receipt number R000003973
Scientific Title Phase 1-2 Study of Amrubicin plus Nedaplatin for Advanced Non-Small-Cell Lung Cancer
Date of disclosure of the study information 2010/03/03
Last modified on 2016/05/17 12:02:47

No. Disposal Last modified on Item of update
1 Insert 2010/03/02 22:41:23
2 Update 2011/05/11 22:34:11 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
3 Update 2011/05/11 22:49:58 Organization
Organization
Division name
Division name
Address
TEL
Institutions
4 Update 2012/05/22 20:39:48 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
5 Update 2013/03/11 22:02:42 Co-sponsor
Co-sponsor
Post marketing survey by drug manufacture etc., specified by Japanese law.
Institutions
6 Update 2013/03/11 22:06:05 Date of closure to data entry
7 Update 2016/05/17 11:56:22 TEL
Email
Address
Name of primary person or sponsor
Organization
8 Update 2016/05/17 12:02:48 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded